Haematopoietic stem cell transplants should be a second-line therapy for highly active MS - NO

Per Soelberg Sorensen*

*Corresponding author for this work
4 Citations (Scopus)
Original languageEnglish
JournalMultiple Sclerosis
Volume22
Issue number10
Pages (from-to)1260-1263
Number of pages4
ISSN1352-4585
DOIs
Publication statusPublished - 2016

Cite this